End-Stage Kidney Disease: Clinical Trials

3 trials for End-Stage Kidney Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow End-Stage Kidney Disease: new trials by email Literature Review of End-Stage Kidney Disease trials Research Report on End-Stage Kidney Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
MK-2060, Placebo - End-Stage Renal Disease, End-Stage Kidney Disease
Phase 2CompletedMerck Sharp & Dohme LLC5062021-09-172026-02-11
Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Vitamin K1, Microcrystalline Methylcellulose - End-stage Kidney Disease
Phase 2CompletedDr. Rachel Holden852012-11-012021-06-28
Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
Rosuvastatin - End-stage Kidney Disease, Diabetes Mellitus
Phase 2CompletedNational Cheng-Kung University Hospital602012-11-012019-02-19

Narrower conditions

Kidney Failure, Chronic (3)  ·  Arteriovenous Fistula (1)  ·  Diabetes Mellitus (1)  ·  Renal Insufficiency, Chronic (1)  ·  Vascular Calcification (1)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Renal Insufficiency (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Renal Insufficiency, Chronic (2)  ·  Arteriovenous Malformations (1)

Interventions

Rosuvastatin Calcium (1)  ·  Vitamin K 1 (1)

Sponsors

Dr. Rachel Holden (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Cheng-Kung University Hospital (1)

Countries

Canada (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Portugal (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  Russia (1)  ·  Sweden (1)  ·  Taiwan (1)

Top investigators

Jun-Neng Roan, MD, PhD (1)  ·  Rachel Holden (1)

Results publications

PMID 26075081, PMID 35641194